Paper Details

  1. Home
  2. Paper Details

Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis.

Author: AlbertKenneth S, AlmasMary, HettiarachchiJayasena, MartinVincent T, ParsonsBruce, SikesCarolyn, ValadeDominique

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared the efficacy and tolerability of eletriptan 20 mg, 40 mg, and 80 mg in triptan-naïve patients versus triptan-experienced patients. The study found that eletriptan has comparable efficacy versus placebo among both triptan-naïve and triptan-experienced patients.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To compare the efficacy and tolerability of eletriptan 20 mg, 40 mg, and 80 mg in triptan-naïve patients (who have not previously used triptans) versus triptan-experienced patients (who have previously used triptans). METHODS: Efficacy and tolerability data for eletriptan 20 mg, 40 mg, a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1526-4610.2006.00685.x

データ提供：米国国立医学図書館（NLM）

Eletriptan: A Reliable Oasis in the Desert of Migraines

Migraines, a debilitating condition that can severely impact a person's quality of life, are often described as a relentless storm, much like a desert sandstorm that can disrupt life's rhythm. This study investigates the efficacy of eletriptan, a triptan medication, in treating migraine headaches, a strategy akin to seeking a safe haven in the midst of a raging desert storm.

A Consistent and Effective Treatment Option

The researchers conducted a combined analysis of data from multiple clinical trials, a process similar to meticulously studying different routes through a vast and challenging desert landscape. Their findings demonstrate that eletriptan is consistently effective in treating migraine headaches, regardless of whether the patient has previous experience with triptans. This is like discovering a reliable oasis that provides relief and sustenance, regardless of the traveler's past experiences.

Finding Relief in the Desert of Migraines

This research offers valuable insights into the treatment of migraines, a condition that can significantly impact a person's well-being. The study's findings suggest that eletriptan may be a reliable and effective treatment option, offering a potential oasis in the desert of migraines.

Dr.Camel's Conclusion

This research provides a reassuring roadmap for navigating the complex terrain of migraines, a condition that can feel like a relentless desert storm. The study's findings suggest that eletriptan may offer a consistent and effective treatment option, potentially leading to a better quality of life for those who struggle with this challenging condition.

Date :
  1. Date Completed 2007-04-17
  2. Date Revised 2012-11-15
Further Info :

Pubmed ID

17300357

DOI: Digital Object Identifier

10.1111/j.1526-4610.2006.00685.x

Related Literature

Article Analysis
・Effects of eletriptan
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.